华润双鹤：全资子公司部分药品取得注册证

Core Viewpoint - China Resources Double Crane announced that its wholly-owned subsidiaries have received drug registration certificates for several medications from the National Medical Products Administration [1] Group 1: Company Developments - Beijing Wanhui Double Crane Pharmaceutical Co., Ltd., China Resources Double Crane Limin Pharmaceutical (Jinan) Co., Ltd., and Double Crane Pharmaceutical (Hainan) Co., Ltd. have each received drug registration certificates for Amlodipine Benazepril Capsules, Tocilizumab Sustained-Release Tablets, and Valsartan Fumarate Tablets respectively [1]